In the next podcast from Johns Hopkins Kimmel Cancer Center Director Dr Bill Nelson, he talks with Dr Trinity Bivalacqua, the Director of Urologic Oncology at the Johns Hopkins Brady Urologic Institute and the Deputy Director of the Johns Hopkins Greenberg Bladder Cancer Institute, about the treatment options for bladder cancer. 
 
In this preview, Dr Bivalacqua explains how doctors first started using immunotherapy with bladder cancer patients. To listen to the full podcast, click here: http://bit.ly/2TyCGtE
VN:F [1.9.17_1161]
Rating: 0.0/5 (0 votes cast)
Share This Post